SHILPA MEDICARE
|
The Current P/E Ratio of SHILPA MEDICARE is 76.02.
Share Price | ₹852.0 | Aug 21,2025 |
Market Cap | ₹8,332.1 Cr | |
Earnings-TTM | ₹109.6 Cr | TTM-Consolidated Results |
Price/Earnings | 76.02x | Calculated as Market Cap/Earnings |
---|---|---|
Explore Stock Analytics |
Definition & Calculation of PE (Price/Earnings) ratio of SHILPA MEDICARE
P/E =
Market Capitalization
/ Net Income
or, using per-share numbers:
P/E = Stock Price /
Earnings Per Share (EPS)
Current Market Cap [ ₹8,332.1 Cr] as on Aug 21,2025
(/) Earnings [ ₹109.6 Cr] based on TTM-Consolidated Results
(=) P/E Ratio [ 76.02x ]
Thus, for SHILPA MEDICARE , the investors are currently willing to pay 76.02 times earnings to own 1 share of the company.
PE Multiples are the most widely used valuation multiple in practice.
Since P/E ratio uses Net Income in the calculation, P/E multiples are not always reliable for valuing companies with negative earnings.
In such cases, you may consider using Price to Book ratio or Price to Sales ratio of SHILPA MEDICARE !
P/E ratios, also, would not adjust for differences in the capital structure between companies.
The chart below summarizes the trend in P/E Ratio of SHILPA MEDICARE over the last five years.
Historical PE (Price/Earnings) ratio chart of SHILPA MEDICARE
PE Ratio Performance Analysis for SHILPA MEDICARE
- SHILPA MEDICARE 's p/e ratio for fiscal years ending Mar2024 to Mar2020 averaged 42.73x.
- SHILPA MEDICARE 's operated at median p/e ratio of 18.41x from fiscal years ending March 2018 to 2022.
- Looking back at the last 5 fiscal years, SHILPA MEDICARE 's p/e ratio peaked in Mar2024 at 125.64x.
- SHILPA MEDICARE 's p/e ratio hit its five-year low in Mar2023 of 0x.
How does SHILPA MEDICARE 's P/E Ratio benchmark against top 10 peers in Pharmaceuticals & Drugs Industry?
Peer Comparison (Pharmaceuticals & Drugs Industry) | Earnings-TTM (Cr) | PE Ratio | Market Cap |
---|---|---|---|
SHILPA MEDICARE | 109.60 | 76.02 | 8,332.1 |
SUN PHARMACEUTICAL INDUSTRIES LTD | 10,411.50 | 37.79 | 393,419.0 |
DIVIS LABORATORIES LTD | 2,306.00 | 69.38 | 159,986.0 |
CIPLA LTD | 5,406.81 | 23.80 | 128,659.0 |
TORRENT PHARMACEUTICALS LTD | 2,002.00 | 61.66 | 123,448.0 |
DR REDDYS LABORATORIES LTD | 5,726.70 | 18.60 | 106,539.0 |
MANKIND PHARMA LTD | 1,905.51 | 56.33 | 107,334.0 |
ZYDUS LIFESCIENCES LTD | 4,637.80 | 21.40 | 99,229.8 |
LUPIN LTD | 3,722.18 | 24.07 | 89,610.7 |
AUROBINDO PHARMA LTD | 3,417.93 | 17.68 | 60,420.8 |
ABBOTT INDIA LTD | 1,452.29 | 47.71 | 69,292.8 |
Pharmaceuticals & Drugs Industry Benchmark (Top 10) PE Analysis vs SHILPA MEDICARE 's P/E Ratio
Top 10 Industry Peers | PE Ratio |
---|---|
Min industry PE | 17.68x |
Max industry PE | 76.02x |
Median industry PE | 37.79x |
Average industry PE | 41.31x |
You may also like the below Video Courses